Stanford Chronic Pancreatitis Clinical Center
The Stanford Clinical Center for the Chronic Pancreatitis Research Consortium (CPCRC)
This project follows adults and children with recurrent acute or chronic pancreatitis to collect medical information and biological samples to find immune-related markers tied to symptoms and outcomes.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11218842 on NIH RePORTER |
What this research studies
As someone with pancreatitis, joining means sharing health information and giving blood or other small samples over time so doctors can study how the immune system affects flare-ups and long-term problems. The Stanford center enrolls adults in the PROCEED cohort and children in the INSPPIRE2 pediatric cohort and contributes samples to the multi-site consortium. Researchers will use clinical data, imaging, and prospectively collected specimens to validate immune signaling markers they previously identified and link those markers to diagnosis, progression, and complications. A team of pancreatitis clinicians, radiologists, endocrinologists, and immunologists will coordinate collection, follow-up, and laboratory studies to improve future care.
Who could benefit from this research
Good fit: Ideal candidates are adults and children with a history of recurrent acute pancreatitis or diagnosed chronic pancreatitis who can attend clinic visits and provide biological samples and medical information.
Not a fit: People without pancreatitis, those unable to provide samples or attend follow-up visits, or those seeking immediate treatment benefit rather than contributing to long-term research are unlikely to receive direct benefit.
Why it matters
Potential benefit: If successful, this work could lead to better tests to detect or predict chronic pancreatitis changes earlier and help guide more personalized care.
How similar studies have performed: Prior work within the consortium has shown promising immune-signaling markers using PROCEED samples, but wider validation and linkage to clinical outcomes remain needed.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Park, Walter Gwang-Up — Stanford University
- Study coordinator: Park, Walter Gwang-Up
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.